welcome to oneGRAVESvoice
- a positively charged Graves' disease and thyroid eye disease community.- join today!
- log in
Current Trends in Antithyroid Drug Treatment of Graves’ Disease
source: Expert Opinion on Pharmacotherapy
year: 2016
authors: Okosieme OE, Lazarus JH
summary/abstract:Introduction:
Graves’ hyperthyroidism is associated with significant morbidity and mortality risk. The thionamides, methimazole, its pro-drug derivative carbimazole, and propylthiouracil, remain a cornerstone of management. Yet despite decades of use, optimal strategies for maximising treatment response and curtailing adverse effect risk remains uncertain.
Areas Covered:
We reviewed the current literature on the evidence based medical management of Graves’ disease. Specifically, we evaluated current approaches to the use of thionamides, adjunctive therapies, and potential novel agents for controlling Graves’ hyperthyroidism.
Expert Opinion:
Primary medical therapy is successful in less than 50% of cases and so careful selection of patients for medical treatment based on a combination of pathological and pragmatic considerations is essential. Carbimazole or methimazole is the treatment of choice in the non-pregnant population driven by its more favourable pharmacokinetic and adverse effect profile over propylthiouracil. In pregnancy the choice of treatment is less straightforward and an approach that minimises undue fetal exposure to all thionamides should be adopted. Additional data is needed on the value of adjunctive therapies including potassium perchlorate, iodides, glucocorticoids, lithium, and cholestyramine. Novel agents directed against pathogenetic targets including TSH receptor blocking monoclonal antibodies and small molecule antagonists may hold promise for the future.
DOI: 10.1080/14656566.2016.1232388
rareRelated
-
Impaired Decision Making Under Risky Conditions in the Acute Phase of Graves’ ThyroitoxicosisThe patients with Graves' thyroitoxicosi...
-
Total Thyroidectomy (Tx) Versus Thionamides (Antithyroid Drugs) in Patients With Moderate-to-Severe Graves’ Op...Background: Graves' disease (GD) is cha...
-
Radioiodine Therapy for Juvenile Graves’ Disease: A Single Institution Experience in Japan (Poster 317)131I radioiodine therapy (RIT) has been ...
-
Subclinical Hypothyroidism After 131I-Treatment of Graves’ Disease: A Risk Factor for Depression?Objectives: Although it is well accepte...
-
National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and ...Background: Current evidence on the i...
-
Comparative Effectiveness of Treatment Choices for Graves’ Hyperthyroidism: A Historical Cohort StudyBackground: The optimum therapy for Gra...
-
Hyperthyroidism: Should I Use Antithyroid Medicine or Radioactive Iodine?You may want to have a say in this decis...